NCT01759355View on ClinicalTrials.gov

Hybrid PET/MR in the Therapy of Cervical Cancer

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

May 28, 2020

Study Completion Date

May 28, 2020

Conditions
Cervix CarcinomaCervical Squamous Cell CarcinomaCervical Adenosquamous Carcinoma
Interventions
PROCEDURE

FDG PET/MR

Participants will undergo a FDG, gadolinium enhanced PET/MR scan.

Trial Locations (1)

27599

University of North Carolina-Chapel Hill, Chapel Hill

All Listed Sponsors
lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT01759355 - Hybrid PET/MR in the Therapy of Cervical Cancer | Biotech Hunter | Biotech Hunter